# Salvational Intervention for Reducing AECOPD Under Severe Air Pollution

> **NCT03083067** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 402 (actual)

## Conditions studied

- COPD Exacerbation
- Air Pollution

## Interventions

- **DRUG:** Budesonide/formoterol
- **DRUG:** tiotropium bromide

## Key facts

- **NCT ID:** NCT03083067
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2022-03-16
- **Final completion:** 2022-03-16
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03083067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03083067, "Salvational Intervention for Reducing AECOPD Under Severe Air Pollution". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03083067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*